As of 2025-06-30, the Intrinsic Value of Abbvie Inc (ABBV) is 115.21 USD. This Abbvie valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 185.62 USD, the upside of Abbvie Inc is -37.90%.
The range of the Intrinsic Value is 59.01 - 369.54 USD
Based on its market price of 185.62 USD and our intrinsic valuation, Abbvie Inc (ABBV) is overvalued by 37.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 59.01 - 369.54 | 115.21 | -37.9% |
| DCF (Growth 10y) | 76.95 - 413.36 | 138.19 | -25.6% |
| DCF (EBITDA 5y) | 33.68 - 49.33 | 44.23 | -76.2% |
| DCF (EBITDA 10y) | 50.67 - 73.35 | 64.27 | -65.4% |
| Fair Value | 19.10 - 19.10 | 19.10 | -89.71% |
| P/E | 37.44 - 60.99 | 50.71 | -72.7% |
| EV/EBITDA | 26.39 - 178.63 | 105.21 | -43.3% |
| EPV | 124.42 - 171.05 | 147.73 | -20.4% |
| DDM - Stable | 29.78 - 132.69 | 81.24 | -56.2% |
| DDM - Multi | 69.37 - 192.95 | 97.24 | -47.6% |
| Market Cap (mil) | 327,879.16 |
| Beta | 0.34 |
| Outstanding shares (mil) | 1,766.40 |
| Enterprise Value (mil) | 392,593.16 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.60% |
| Cost of Debt | 4.54% |
| WACC | 6.94% |